# Chia Blood Glucose Meta-analysis: What the Evidence Says
Canonical: https://www.migaku.app/guides/chia-blood-glucose-meta-analysis-evidence-review
Category: evidence-review
Summary: Chia Blood Glucose Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed 
Last reviewed: 2026-08-03
Reviewed by: Migaku Evidence Review
# Chia Blood Glucose Meta-analysis: What the Evidence Says

## Quick Answer

Chia Blood Glucose Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public-health sources, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 observational study, 1 preclinical study.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Patient decision aid–supported shared decision making and short-term decision-making outcomes in type 2 diabetes: a prospective observational comparative study | observational study | 3 | 2026-03-11 | 10.1186/s12911-026-03426-z |
| Causal relationships between insomnia and blood metabolome: a Mendelian randomization study with mouse experimental validation | preclinical study | 4 | 2026-05-24 | 10.1007/s11306-026-02450-4 |

## What The Sources Report

- Numerous large-scale clinical studies have confirmed that blood glucose control in diabetic patients can effectively reduce the risk of cardiovascular diseases and mortality. [Hsu Su-Han (2026); evidence level 3]
- A clinical trial published in 2000 demonstrated that for patients with type 2 diabetes, a 1% reduction in HbA1c was associated with a 14% decrease in the risk of myocardial infarction, a 21% reduction in diabetes-related mortality, and a 37% reduction in complications related to peripheral vascular disease. [Hsu Su-Han (2026); evidence level 3]
- For example, fatty acids like α-linolenic acid have been found to influence sleep duration (Liu & Shan,). [Fan Hsien-Yu (2026); evidence level 4]
- In contrast, studies have established connections between sleep disturbances and specific blood metabolites, including amino acids and fatty acids (Lv et al.,), which are associated with conditions like sleep-related disorders. [Fan Hsien-Yu (2026); evidence level 4]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

For chia blood glucose meta-analysis, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Hsu Su-Han (2026). Patient decision aid–supported shared decision making and short-term decision-making outcomes in type 2 diabetes: a prospective observational comparative study. DOI: 10.1186/s12911-026-03426-z. PMCID: PMC13088564. PMID: 41814312. License: https://creativecommons.org/licenses/by-nc-nd/4.0/ http://creativecommons.org/licenses/by-nc-nd/4.0/ This article is .... https://pmc.ncbi.nlm.nih.gov/articles/PMC13088564/
- Fan Hsien-Yu (2026). Causal relationships between insomnia and blood metabolome: a Mendelian randomization study with mouse experimental validation. DOI: 10.1007/s11306-026-02450-4. PMCID: PMC13199183. PMID: 42177678. License: https://creativecommons.org/licenses/by-nc-nd/4.0/ http://creativecommons.org/licenses/by-nc-nd/4.0/ This article is .... https://pmc.ncbi.nlm.nih.gov/articles/PMC13199183/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.